BMN053

· BioMarin Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMN053, covering 2017-12-08 to 2017-12-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD) [Phase 1, Phase 2]